Merck Sharp & Dohme-Chibret

MSD France, historically known as Merck Sharp & Dohme-Chibret, is the French subsidiary of the global biopharmaceutical leader Merck & Co., Inc. The company is a major player in the French healthcare sector, focusing on the development and commercialization of innovative medicines and vaccines. Its portfolio is heavily weighted toward oncology, particularly with its leading immunotherapy, as well as a comprehensive range of vaccines for pediatric and adult populations. MSD France also maintains a significant industrial footprint in the country, notably through its manufacturing facility in Riom, which serves as a global hub for ophthalmic products. The organization is actively involved in the French research ecosystem through numerous clinical trials and partnerships with academic institutions.